- Home
- TFII vs LEGN Comparison
TFII vs LEGN Comparison
Compare TFII & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFII
- LEGN
- Stock Information
- Founded
- TFII 1957
- LEGN 2014
- Country
- TFII Canada
- LEGN United States
- Employees
- TFII N/A
- LEGN N/A
- Industry
- TFII Trucking Freight/Courier Services
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- TFII Industrials
- LEGN Health Care
- Exchange
- TFII Nasdaq
- LEGN Nasdaq
- Market Cap
- TFII 7.4B
- LEGN 6.3B
- IPO Year
- TFII N/A
- LEGN 2020
- Fundamental
- Price
- TFII $91.12
- LEGN $32.06
- Analyst Decision
- TFII Buy
- LEGN Strong Buy
- Analyst Count
- TFII 10
- LEGN 12
- Target Price
- TFII $117.50
- LEGN $73.36
- AVG Volume (30 Days)
- TFII 250.2K
- LEGN 1.3M
- Earning Date
- TFII 10-20-2025
- LEGN 11-11-2025
- Dividend Yield
- TFII 1.98%
- LEGN N/A
- EPS Growth
- TFII N/A
- LEGN N/A
- EPS
- TFII 4.34
- LEGN N/A
- Revenue
- TFII $8,263,477,999.00
- LEGN $796,838,000.00
- Revenue This Year
- TFII N/A
- LEGN $69.31
- Revenue Next Year
- TFII $4.21
- LEGN $52.73
- P/E Ratio
- TFII $20.56
- LEGN N/A
- Revenue Growth
- TFII 3.10
- LEGN 74.75
- 52 Week Low
- TFII $72.02
- LEGN $27.34
- 52 Week High
- TFII $155.12
- LEGN $51.77
- Technical
- Relative Strength Index (RSI)
- TFII 48.25
- LEGN 35.26
- Support Level
- TFII $86.56
- LEGN $32.02
- Resistance Level
- TFII $94.65
- LEGN $33.60
- Average True Range (ATR)
- TFII 2.06
- LEGN 1.03
- MACD
- TFII -0.41
- LEGN -0.04
- Stochastic Oscillator
- TFII 43.10
- LEGN 13.25
About TFII TFI International Inc.
TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.